Propel Bio Management, LLC / OCUL
Propel Bio Management, LLC’s Ocular Therapeutix Inc Position
Does Propel Bio Management, LLC own Ocular Therapeutix Inc (OCUL)? Yes — 382.4K shares worth $3M (+2.03% of its 13F portfolio) as of Q1 2026.
Position Value
$3M
Q1 2026
Shares
382.4K
% of Portfolio
+2.03%
Quarters Held
1
currently held
Position History OCUL
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 382.4K | $3M | +2.03% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of OCUL.